Extranodal NK-T-cell lymphoma risk factors
Jump to navigation
Jump to search
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma risk factors On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma risk factors |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.
Risk Factors
- There is a strong association between with extranodal NK/T-cell lymphoma and EBV virus.[1]
- Studies revealed that there is a constant assosiation between NK/T-cell lymphoma with EBV in the world.[2][3][4]
- There is a strong assosiation between Extranodal NK/T-cell lymphoma andFas(Po-1/CD95) mutations.[5]
References
- ↑ Ng SB, Khoury JD (2009). "Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist". Adv Anat Pathol. 16 (1): 40–55. doi:10.1097/PAP.0b013e3181916029. PMID 19098466.
- ↑ Kanavaros P, Lescs MC, Brière J, Divine M, Galateau F, Joab I; et al. (1993). "Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus". Blood. 81 (10): 2688–95. PMID 8387835.
- ↑ Mishima, Kenji; Horiuchi, Keisuke; Kojya, Shizuo; Takahashi, Hiroomi; Ohsawa, Masahiko; Aozasa, Katsuyuki (1994). "Epstein-barr virus in patients with polymorphic reticulosis (lethal midline granuloma) from china and japan". Cancer. 73 (12): 3041–3046. doi:10.1002/1097-0142(19940615)73:12<3041::AID-CNCR2820731224>3.0.CO;2-K. ISSN 0008-543X.
- ↑ Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F; et al. (1990). "Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma". Lancet. 335 (8682): 128–30. doi:10.1016/0140-6736(90)90002-m. PMID 1967431.
- ↑ Suda T, Takahashi T, Golstein P, Nagata S (1993). "Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family". Cell. 75 (6): 1169–78. doi:10.1016/0092-8674(93)90326-l. PMID 7505205.